N/A
Completed N=1,005
Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial
High-risk Medications
Source: ClinicalTrials.gov NCT02785458 ↗
Enrolled (actual)
1,005
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcomePrimary: Medication Knowledge (0-100) — 71.2; 71.9; 73.2; 74.9 score on a scale
Summary
This study evaluates the effectiveness of an electronic health record based educational intervention (the EMC2 strategy) to improve patient understanding and use of higher-risk medications. Half of the participants will receive the intervention, while the other half will receive the usual amount of information (usual care).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Knowledge (0-100) |
71.2; 71.9; 73.2; 74.9; 73.2; 75.0 | — |
| SECONDARY Probability of Prescription Medication Proper Use |
0.84; 0.81; 0.83; 0.80 | — |
Eligibility Criteria
Inclusion Criteria
- 21 and older
- English or spanish speaking
- Primarily responsible for administering own medications
- New prescription of one of 66 study medications on day of recruitment
- Has a personal mobile or land line phone
Exclusion Criteria
- Severe, uncorrectable vision
- Hearing or cognitive impairments
Data sourced from ClinicalTrials.gov (NCT02785458). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.